Annual Accounts Payable
$4.74 M
-$1.27 M-21.09%
December 31, 2023
Summary
- As of February 7, 2025, GPCR annual accounts payable is $4.74 million, with the most recent change of -$1.27 million (-21.09%) on December 31, 2023.
- During the last 3 years, GPCR annual accounts payable has risen by +$3.21 million (+210.54%).
- GPCR annual accounts payable is now -21.09% below its all-time high of $6.01 million, reached on December 31, 2022.
Performance
GPCR Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$8.45 M
+$6.24 M+282.39%
September 30, 2024
Summary
- As of February 7, 2025, GPCR quarterly accounts payable is $8.45 million, with the most recent change of +$6.24 million (+282.39%) on September 30, 2024.
- Over the past year, GPCR quarterly accounts payable has increased by +$5.13 million (+154.50%).
- GPCR quarterly accounts payable is now at all-time high.
Performance
GPCR Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
GPCR Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.1% | +154.5% |
| 3 y3 years | +210.5% | +154.5% |
| 5 y5 years | +210.5% | +154.5% |
GPCR Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -21.1% | +36.1% | at high | +282.4% |
| 5 y | 5-year | -21.1% | +210.5% | at high | +282.4% |
| alltime | all time | -21.1% | +210.5% | at high | +282.4% |
Structure Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.45 M(+282.4%) |
| Jun 2024 | - | $2.21 M(-66.2%) |
| Mar 2024 | - | $6.54 M(+37.9%) |
| Dec 2023 | $4.74 M | $4.74 M(+42.9%) |
| Sep 2023 | - | $3.32 M(-41.8%) |
| Jun 2023 | - | $5.70 M(+15.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $4.95 M(-17.7%) |
| Dec 2022 | $6.01 M(+72.5%) | $6.01 M(+5.4%) |
| Sep 2022 | - | $5.70 M(+63.7%) |
| Dec 2021 | $3.48 M(+128.2%) | - |
| Dec 2021 | - | $3.48 M |
| Dec 2020 | $1.53 M | - |
FAQ
- What is Structure Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Structure Therapeutics?
- What is Structure Therapeutics annual accounts payable year-on-year change?
- What is Structure Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Structure Therapeutics?
- What is Structure Therapeutics quarterly accounts payable year-on-year change?
What is Structure Therapeutics annual accounts payable?
The current annual accounts payable of GPCR is $4.74 M
What is the all time high annual accounts payable for Structure Therapeutics?
Structure Therapeutics all-time high annual accounts payable is $6.01 M
What is Structure Therapeutics annual accounts payable year-on-year change?
Over the past year, GPCR annual accounts payable has changed by -$1.27 M (-21.09%)
What is Structure Therapeutics quarterly accounts payable?
The current quarterly accounts payable of GPCR is $8.45 M
What is the all time high quarterly accounts payable for Structure Therapeutics?
Structure Therapeutics all-time high quarterly accounts payable is $8.45 M
What is Structure Therapeutics quarterly accounts payable year-on-year change?
Over the past year, GPCR quarterly accounts payable has changed by +$5.13 M (+154.50%)